CYTOMEGALOVIRUS INFECTIONS
Clinical trials for CYTOMEGALOVIRUS INFECTIONS explained in plain language.
Never miss a new study
Get alerted when new CYTOMEGALOVIRUS INFECTIONS trials appear
Sign up with your email to follow new studies for CYTOMEGALOVIRUS INFECTIONS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Experimental immune cell therapy for transplant viruses shows early promise but study halted
Disease control TerminatedThis early-stage trial tested whether specially grown immune cells could help transplant patients fight off stubborn viral infections. The study included 8 people who had received a stem cell or organ transplant and had ongoing infections with adenovirus, CMV, or EBV. The approac…
Matched conditions: CYTOMEGALOVIRUS INFECTIONS
Phase: PHASE1, PHASE2 • Sponsor: Jessie L. Alexander, MD • Aim: Disease control
Last updated Jun 27, 2026 12:37 UTC
-
New antibody treatment aims to shield transplant patients from dangerous virus
Disease control TerminatedThis study tested a drug called Cytotect, which contains antibodies against the CMV virus, to prevent CMV infection in people who had a stem cell transplant and developed graft-versus-host disease (GVHD). These patients are at high risk for CMV, and current antiviral drugs often …
Matched conditions: CYTOMEGALOVIRUS INFECTIONS
Phase: PHASE2 • Sponsor: University Hospital, Lille • Aim: Disease control
Last updated Jun 27, 2026 07:52 UTC